Latest Market News

Regal Asian Investments Limited posted a sharp 92% decline in net profit for FY25 amid volatile Asian markets but maintained a fully franked 6 cent dividend and continued its on-market share buy-back program.

Kogan.com has recorded a significant non-cash goodwill impairment related to its Mighty Ape acquisition, reflecting ongoing challenges in New Zealand’s retail market and delayed technology recovery.

Pacgold Limited advances its Northern Queensland footprint with a maiden 900,000-ounce gold resource at Alice River and a new high-grade antimony acquisition at St George, positioning itself amid critical mineral supply challenges.

Pacgold Limited has entered a farm-in agreement to acquire up to 100% of the St George Gold-Antimony Project in North Queensland, unlocking exposure to a critical mineral with soaring prices and strong geopolitical demand.

Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.

360 Capital REIT (ASX – TOT) has reported a return to profitability in FY25, extending its debt facility and completing key leasing deals, while preparing for leasing challenges in FY26.

Highfield Resources faces a setback as China Minmetals and its subsidiary withdraw from a key strategic investment, triggering the maturity of convertible notes and raising questions about the future financing of the Muga potash project.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

Pure Resources reaffirms exceptional metallurgical results at its Garnet Hills Project, achieving garnet grades up to 98% through sustainable processing. The company is now scaling up testing and forging strategic collaborations in the US to unlock downstream rare earth opportunities.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Star Minerals Limited has voluntarily suspended trading on the ASX pending an important announcement related to assay results and a price query. The suspension is expected to last until 20 August or until the announcement is released.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.